Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LCK | P06239 | 1/20 | 0.70 |
| ▸ | PLAU | P00749 | 2/20 | 0.61 |
| ▸ | CES2 | O00748 | 1/20 | 0.59 |
| ▸ | CES1 | P23141 | 1/20 | 0.59 |
| ▸ | F2 | P00734 | 1/20 | 0.55 |
| ▸ | PLG | P00747 | 1/20 | 0.55 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.55 |
| ▸ | KLK1 | P06870 | 1/20 | 0.55 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.55 |
| ▸ | PARP1 | P09874 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | EGFR | P00533 | 1/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8161748 | 1.00 | LCK (0.70) | LCKPLAUCES2CES1F2 | |
| SCHEMBL30350858 | 1.00 | LCK (0.70) | LCKPLAUCES2CES1F2 | |
| SCHEMBL30277311 | 1.00 | LCK (0.70) | LCKPLAUCES2CES1F2 | |
| Hydrochloric Acid SCHEMBL27922456 | 0.98 | LCK (0.68) | LCKPLAUCES2CES1F2 | |
| SCHEMBL28074925 | 0.98 | LCK (0.68) | LCKPLAUCES2CES1F2 | |
| SCHEMBL546633 | 0.93 | CES2 (0.68) | LCKPLAUCES2CES1F2 | |
| SCHEMBL29462782 | 0.93 | CES2 (0.68) | LCKPLAUCES2CES1F2 | |
| SCHEMBL26903783 | 0.93 | CES2 (0.68) | LCKPLAUCES2CES1F2 | |
| Hydrochloric Acid SCHEMBL8358165 | 0.91 | CES2 (0.65) | LCKPLAUCES2CES1F2 | |
| Hydrochloric Acid SCHEMBL22558829 | 0.91 | CES2 (0.65) | LCKPLAUCES2CES1F2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 175 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210393695-A1 | COMPOSITIONS AND METHODS FOR IMMUNE CELL MODULATION IN ADOPTIVE IMMUNOTHERAPIES | FATE THERAPEUTICS, INC. | 2021-12-23 | — | — | US | claimed |
| CN-109563035-A | The crystal form of tetracycline compound and preparation method thereof that 9- amino methyl replaces | 山东亨利医药科技有限责任公司 | 2019-04-02 | — | — | CN | claimed |
| CN-105008382-B | Estra-1, 3,5(10), 16-tetraene-3-carboxamides for the inhibition of 17 β -hydroxysteroid dehydrogenase (AKR 1C 3) | 拜耳医药股份公司 | 2018-01-30 | — | — | CN | claimed |
| US-20050227266-A1 | Biomarker:compound correlations in cancer diagnosis and therapy | APPLIED GENOMICS, INC. | 2005-10-13 | — | — | US | claimed |
| WO-2005085863-A2 | BIOMARKER: COMPOUND CORRELATIONS IN CANCER DIAGNOSIS AND THERAPY | APPLIED GENOMICS, INC. (US) | 2005-09-15 | — | — | WO | claimed |
| US-12419870-B2 | Compositions and methods for immune cell modulation in adoptive immunotherapies | FATE THERAPEUTICS, INC. (US) | 2025-09-23 | — | — | US | disclosed |
| US-20250215396-A1 | COMPOSITIONS AND METHODS FOR IMMUNE CELL MODULATION IN ADOPTIVE IMMUNOTHERAPIES | FATE THERAPEUTICS, INC. | 2025-07-03 | — | — | US | disclosed |
| CN-120157555-A | Preparation method of primary amide compound | 浙江工业大学 | 2025-06-17 | — | — | CN | disclosed |
| US-12281329-B2 | Compositions and methods for immune cell modulation in adoptive immunotherapies | FATE THERAPEUTICS, INC. (US) | 2025-04-22 | — | — | US | disclosed |
| US-20250024837-A1 | PESTICIDE SYSTEM | BANISH, MICHELE | 2025-01-23 | — | — | US | disclosed |
| US-20240263135-A1 | COMPOSITIONS AND METHODS FOR IMMUNE CELL MODULATION IN ADOPTIVE IMMUNOTHERAPIES | FATE THERAPEUTICS, INC. | 2024-08-08 | — | — | US | disclosed |
| CN-118414330-A | Naphthalene and quinoline analogs as RXFP1 agonists | 百时美施贵宝公司 | 2024-07-30 | — | — | CN | disclosed |
| CN-1072172-A | Novel 7-replacement-9-substituted-amino-6-demethyl-6-deoxidation tsiklomitsin | AMERICAN CYANAMID CO (US) | 1993-05-19 | — | — | CN | disclosed |
| EP-0409957-A4 | BIOLOGICAL FLUIDS PURIFICATION SYSTEMS | — | 1993-01-07 | — | — | EP | disclosed |
| US-5149718-A | BIOLOGICAL FLUID PURIFICATION SYSTEM | NEW YORK UNIVERSITY (US) | 1992-09-22 | — | — | US | disclosed |
| EP-0426785-A4 | COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS | — | 1991-11-13 | — | — | EP | disclosed |
| EP-0426785-A1 | COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS | NEW YORK UNIVERSITY (US) | 1991-05-15 | — | — | EP | disclosed |
| EP-0409957-A1 | BIOLOGICAL FLUIDS PURIFICATION SYSTEMS | NEW YORK UNIVERSITY (US) | 1991-01-30 | — | — | EP | disclosed |
| WO-1990010438-A1 | COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS | NEW YORK UNIVERSITY (US) | 1990-09-20 | — | — | WO | disclosed |
| WO-1990007876-A1 | BIOLOGICAL FLUIDS PURIFICATION SYSTEMS | NEW YORK UNIVERSITY (US) | 1990-07-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250024837-A1 | PESTICIDE SYSTEM | ACHE, PFAS, FPGS | LCK 1938/4885PLAU 1246/4885CES2 52/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.